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Case Study: Preventing the Unnecessary Losses of Alzheimer's Disease  
       by Lin E. Noyes, RN, MSN 
Lin E. Noyes is a charter member of the Alzheimer's Association, Northern Virginia Chapter and was a 
member of the Public Policy Committee of the National Alzheimer's Association from 1989 to 
1994.  From 1986 to 1994 she was also a member of the Virginia Governor's Commission on Alzheimer's 
Disease and Related Disorders, which worked to improve the state's policies and laws regarding people 
with Alzheimer's Disease and other dementias and their family caregivers. 
Currently, Lin is the Director of the Family Respite Center, which provides day care and other services for 
people with dementia and is a Ph.D. candidate at George Mason University in Administration, Health 
Policy, and Ethics in the College of Nursing. 
Educational Objectives 
1. To state the importance of early detection and diagnosis of Alzheimer's disease.  
2. To describe common concerns of people in the early stages of Alzheimer's disease.  
3. To describe interventions to help people who have recently been diagnosed with  
Alzheimer's disease or other dementias. 
Case Study 
Pam K. at 74 years old delighted in telling me about running the Native American Art Gallery and 
working “on the hill” with legislators and lobbyists.  She has had a full life and is now happily married to 
her third husband.  She had driven herself across town this day to ask for my help.  She told me that she 
had been recently diagnosed with Alzheimer’s disease and wanted to join a support group but couldn’t 
find one.  She had heard of the Family Respite Center’s work with people in the later stages of dementia 
and now wanted us to help her.  She was tearful and had some trouble speaking fluently, but was more 
than able to carry on a meaningful conversation. She was quite persuasive in her requests for help.  The 
experience of meeting someone with mild dementia had a profound effect on me.  I soon learned that 
her problems and concerns were more similar to my own than they were similar to people in the middle 
stages of Alzheimer’s.  Our response to Pam, and the other people we began to meet with mild 
dementia, was to start an Early Intervention Program.  Pam is the co-facilitator of the early stage 
support group.  Health education sessions are given once a month after the support group.  We have 
developed a special dinner and discussion group for couples when one spouse has Alzheimer’s 
disease.  It meets once a month in the evening.  After almost one year, there are 5-8 people at each 
support group, up to 20 attending the health education talks, and as many as 10 couples attending the 
monthly dinners.  The response, while slow in the beginning, is now good as the word travels that you 
can do something about Alzheimer’s disease! 
Background 
Alzheimer's disease (A.D.) is a progressive neurologic disorder; the most common cause of dementia 
among older people (NIA, 1996). It is considered that Alzheimer's disease will be the number one public 
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health concern of the 21st century, since its incidence increases with age and those over 85 are the most 
rapidly increasing segment of the U.S. population. 
The good news is that A.D, once shrouded in myths and lack of understanding, is now more easily 
recognized and diagnosed. In addition, research is beginning to yield some treatments for the symptoms 
of Alzheimer's disease. This article will describe the role of the health professional in helping people at 
risk for a dementing illness and those in the early stages of their illness. 
Fifteen years ago Alzheimer's disease was more difficult  to diagnose in the early stages and considered 
impossible to "treat". In fact, health care professionals rarely saw people with A.D. until they had lost 
the ability to care for themselves or they exhibited difficult behavioral problems. Looking back on those 
days one can see that health care professionals treated A.D. in the middle stage and had no specific 
treatments for people at the beginning or the end of their illness. 
Today, because the health community and the public have a greater knowledge of the signs and 
symptoms of Alzheimer's disease, people in the very early stages of Alzheimer's are seeking a diagnosis 
when they are still able to contemplate what their future will be like without  memory and are still able 
to care for themselves. As health professionals, we have an obligation to help people learn about the 
signs and symptoms of this disease and advocate for early diagnosis and treatment. 
Recognition of Symptoms and Diagnosis 
Many more people, older people especially, worry that every occasion of forgetfulness is a sure sign that 
they are "coming down with Alzheimer's disease." In fact, the fear of having Alzheimer's may keep 
people who are experiencing memory loss symptoms from seeking help. This is unfortunate since some 
of the causes of cognitive changes are treatable if diagnosed early. 
Health professionals must recognize people who are at risk, monitor their mental status and advocate 
for diagnosis if symptoms of dementia become apparent. 
Yale (1994), in one of the few books about the early stages of dementia, describes people who are at 
risk and/or who may be in the early stages as those who may have trouble “word finding” or “way 
finding,” or have problems with spatial perceptions or memory problems. These people need little help 
with activities of daily living (ADLs) or instrumental activities of daily living (IADLs) and probably still have 
the capacity for intro-spection and comprehension.  New pharmaco-logical interventions appear to have 
their greatest success in these preliminary phases, and "reversible dementias" are more successfully 
treated before symptoms become more pronounced.  Therefore, health professionals cannot wait to 
see a person failing with ADLs before they advocate for diagnosis. 
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Helping People in the Early Stages 
If an Alzheimer's type dementia is diagnosed by a neurologist after a thorough diagnostic work up, there 
are many things that can be done to help the person, especially in the early stages. 
Pharmacological Interventions  
Aricept (donepezil hydrochloride) is given to people in the early stages of Alzheimer's to increase the 
concentration of acetylcholine in the brain, thereby improving cognitive functioning. This drug is an 
improvement over Cognex (tacrine hydrochloride), the first drug aimed at treating the symptoms of 
A.D., since Aricept is only taken once a day and does not have the high risk of liver toxicity that Cognex 
has. It is a treatment, not a cure, and is most effective in the early stages. People generally experience 
greater word fluency and better recall when taking Aricept. It may also have an effect on the diagnosed 
person's sense of well being, since in the early stages he or she will still be cognizant that something is 
being done.  The improvements vary from person to person, and are modest at best, but definitely 
worth considering, unless there are good medical reasons not to try the medicine. 
Other drugs that physicians may consider prescribing are Vitamin E, Estrogen, and Ibuprofen since all 
have shown some efficacy in research studies. Since drug treatment options are relatively new, finding a 
doctor who keeps current with the research findings in this area may provide the greatest help to the 
diagnosed person. 
Health Education  
Alzheimer's disease is a chronic, debilitating illness. Just like persons with other chronic debilitating 
illnesses, people with A.D. feel that they have more control over their lives when they have information 
about the disease, treatment options, and research efforts taking place on their behalf.  As with many 
other illnesses, educating people about A.D. and separating facts from fiction can help them come to 
terms with what is happening to them. Knowledge empowers people, even if there is little they can do 
to change their situation. While there have been a few widely publicized cases of assisted suicide by 
people in the early stages of Alzheimer's, there is no research to support the notion of increased 
incidence of suicide in persons who know that they have the disease.  People need to know that having 
Alzheimer's disease today is "different" from when their grandmothers had it; treatments and care are 
much better and more humane, and research is moving rapidly toward more effective treatments. 
Support for the Diagnosed Person  
While support groups for family caregivers have been in existence in Virginia for almost twenty years, 
community support groups for people with the diagnosis are very new and very helpful. One person 
diagnosed with A.D. said at the end of a support group, "this group gives me hope."  Another lady who 
was looking forward to attending her first support group meeting said, "I wonder what the other people 
in the group will look like."  The message from both of these comments is that people feel better 
knowing that other "normal" people are in the same situation and benefit from coming together. 
Support groups for people with mild dementia may be difficult to get started until the awareness of the 
benefit of the group increases but are definitely worth the effort and perseverance of the group 
facilitator. 
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Cognitive Exercises  
While there is not an abundance of research data to support it, common sense supports the idea that 
exercising memory and other cognitive skills keeps healthy brain cells functioning longer. Quayhagen, 
Quayhagen, Corbeil, Roth and Rodgers (1995) reported temporary improvements in cognitive and 
behavioral performance with a regimented program of cognitive stimulation in people with mild 
memory impairment. Snowden's (1997) preliminary findings in the  "The Nun's Study" also supports the 
"use it or lose it" theory of encouraging cognitive stimulation and exercising the brain. 
To summarize, people with cognitive changes should be identified, diagnosed and treated. If an 
Alzheimer's type illness is diagnosed, treatment options include medications, education, support, and 
cognitive stimulation. 
Study Questions 
1. Why is an early diagnosis of Alzheimer’s disease important?  
2. What kind of support is available for those diagnosed with Alzheimer’s disease? 
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